Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.
- DOI
- 10.1002/hep.22213
- Published
- 2008 Aug
- Container
- Hepatology (Baltimore, Md.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hep.22213,
title = {Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.},
author = {Hui CK and Cheung WW and Leung KW and Cheng VC and Tang BS and Li IW and Luk JM and Lee NP and Kwong YL and Au WY and Yuen KY and Lau GK and Liang R},
year = {2008},
journal = {Hepatology (Baltimore, Md.)},
doi = {10.1002/hep.22213},
url = {https://doi.org/10.1002/hep.22213}
}RIS
TY - JOUR TI - Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen. AU - Hui CK AU - Cheung WW AU - Leung KW AU - Cheng VC AU - Tang BS AU - Li IW AU - Luk JM AU - Lee NP AU - Kwong YL AU - Au WY AU - Yuen KY AU - Lau GK AU - Liang R PY - 2008 JO - Hepatology (Baltimore, Md.) DO - 10.1002/hep.22213 UR - https://doi.org/10.1002/hep.22213 ER -
APA
CK, H., WW, C., KW, L., VC, C., BS, T., IW, L., JM, L., NP, L., YL, K., WY, A., KY, Y., GK, L., & R, L. (2008). Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen.. Hepatology (Baltimore, Md.). https://doi.org/10.1002/hep.22213
Source records
- pubmed · retrieved 2026-09-25T05:13:07.011Z